Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,250.00    20.00 (1.63%)
Bid:
1,250.00
Ask:
1,270.00
Spread: 20.00 (1.60%)
Market Cap: £572.82m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Share Options

14 Aug 2013 10:38

RNS Number : 6754L
Cohort PLC
14 August 2013
 



14 August 2013 AIM: CHRT

PRESS RELEASE

COHORT PLC ("Cohort")

Share Options

Option Grant

Cohort announces that on 13 August 2013 the following approved options over ordinary shares of 10 pence each were granted to Cohort directors pursuant to the Cohort plc Savings Related Share Option Scheme established on 16 February 2006 (and approved by HM Revenue & Customs on 10 April 2006) ("SAYE Scheme"):

Director

Number of shares under this option

Exercise Price (pence)

Total number of shares under the SAYE Scheme following grant

AS Thomis

2,330

154.5

6,041

SR Walther

5,825

154.5

15,103

 

The options are made pursuant to three year savings contracts.

Option Exercise

Cohort announces that it has issued and allotted 170,164 new ordinary shares of 10p each in the capital of Cohort pursuant to the exercise of share options under the Cohort plc 2006 Share Option Scheme and the SAYE Scheme.

Following this exercise, Cohort's issued share capital consists of 40,958,616 ordinary shares of 10p each with voting rights. Cohort does not hold any shares in treasury.

Therefore, the total number of voting rights in Cohort is 40,958,616. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Cohort under the FCA's Disclosure and Transparency Rules.

Application has been made for admission of these shares to trading on AIM and dealings in the new ordinary shares are expected to commence on 19 August 2013.

 

Ends

 

For further information, please contact

 

Cohort plc

 

Andrew Thomis, Chief Executive

Simon Walther, Finance Director

+44 (0)118 909 0390

 

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins, Ben Griffiths

+44 (0)20 3128 8100

 

 

Cohort plc (www.cohortplc.com) (@Cohortplc)

 

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through three market-facing subsidiary companies:

Ÿ MASS (www.mass.co.uk) - a specialist systems house with considerable experience in the defence market and a focus on information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

 

Ÿ SCS (www.scs-ltd.co.uk) - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

 

Ÿ SEA (www.sea.co.uk) - an advanced surveillance systems and software house with hardware development capability operating in the defence, space and transport market sectors. Acquired by Cohort in October 2007.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire and Somerset.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWSULFDSEDA
Date   Source Headline
16th Jul 20257:00 amRNSFinal Results
11th Jul 20259:00 amRNS-RInvestor Presentation
11th Jul 20257:00 amRNSNotice of Results
9th Jul 202512:11 pmRNSHolding(s) in Company
1st Jul 202511:00 amRNSTotal Voting Rights
29th May 20257:00 amRNSFull Year Trading Update
12th May 20253:59 pmRNSBlock Listing Application
6th May 20252:00 pmRNS-RContract Win (Replacement)
1st May 20259:00 amRNS-RContract win
1st May 20257:00 amRNSTotal Voting Rights
24th Apr 202512:12 pmRNSDirector/PDMR Shareholding
9th Apr 20253:05 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:41 amRNSBlock Listing Six Monthly Return
1st Apr 20259:58 amRNSTotal Voting Rights
31st Mar 202512:53 pmRNSDirector/PDMR Shareholding
3rd Mar 202512:34 pmRNSTotal Voting Rights
24th Feb 20252:57 pmRNSBlock Listing Six Monthly Return
21st Feb 20252:18 pmRNSDirector/PDMR Shareholding
12th Feb 202511:00 amRNS-RInvestor Presentation via Investor Meet Company
12th Feb 20257:00 amRNSMASS wins extension for JCAST training contract
10th Feb 20257:00 amRNS-RCohort presentation at Shares Spotlight Event
5th Feb 20257:00 amRNS-RInvestor Presentation via Engage Investor
3rd Feb 20255:00 pmRNSTotal Voting Rights
31st Jan 20257:00 amRNSCompletion of EM Solutions Acquisition
24th Jan 20257:00 amRNS-RInvestor Presentation
20th Jan 20257:30 amRNSCompletion date of EM Solutions Acquisition
14th Jan 20257:00 amRNSInterim Report 2024
9th Jan 20257:00 amRNSContract Win
6th Jan 202511:25 amRNSHolding(s) in Company
2nd Jan 20254:44 pmRNSTotal Voting Rights
24th Dec 20248:30 amRNSREVISED COMPLETION OF ACQUISITION
16th Dec 20249:52 amRNSHolding(s) in Company
11th Dec 20242:00 pmRNSHalf Year Results (Replacement)
11th Dec 20247:00 amRNSHalf Year Results
2nd Dec 20242:45 pmRNSTotal Voting Rights
28th Nov 202410:00 amRNSNotice of Half Year Results
21st Nov 202411:26 amRNSResult of the Placing
21st Nov 202411:17 amRNSResult of the Retail Offer
21st Nov 20247:01 amRNSProposed Retail Offer to raise up to £1 million
21st Nov 20247:00 amRNSProposed Placing to raise £40 million
21st Nov 20247:00 amRNSAcquisition of EM Solutions
12th Nov 20249:33 amRNSHolding(s) in Company
4th Nov 20245:42 pmRNSHolding(s) in Company
1st Nov 20245:06 pmRNSTotal Voting Rights
21st Oct 202412:18 pmRNSDirector/PDMR Shareholding
4th Oct 20243:21 pmRNSDirector/PDMR Shareholding
2nd Oct 202411:22 amRNSBlock Listing Six Monthly Return
1st Oct 202411:19 amRNSTotal Voting Rights
24th Sep 20247:00 amRNSAGM Statement
20th Sep 202410:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.